End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
14.51 CNY | +2.26% | -14.65% | -35.85% |
Apr. 08 | Hainan Poly Pharm Gets Nod to Market Voriconazole Injection in Sweden | MT |
Apr. 04 | Hainan Poly Pharm Gets Nod to Market Skin Infection Drug in Germany | MT |
Sales 2023 * | 2.05B 283M | Sales 2024 * | 2.38B 328M | Capitalization | 6.51B 899M |
---|---|---|---|---|---|
Net income 2023 * | 473M 65.33M | Net income 2024 * | 550M 75.97M | EV / Sales 2023 * | 3.17 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 2.74 x |
P/E ratio 2023 * |
13.6
x | P/E ratio 2024 * |
11.7
x | Employees | 1,522 |
Yield 2023 * |
0.55% | Yield 2024 * |
0.69% | Free-Float | 57.56% |
1 day | +2.26% | ||
1 week | -14.65% | ||
Current month | -18.62% | ||
1 month | -27.88% | ||
3 months | -25.97% | ||
6 months | -30.67% | ||
Current year | -35.85% |
Managers | Title | Age | Since |
---|---|---|---|
Min Hua Fan
CEO | Chief Executive Officer | 63 | 92-07-13 |
Tong Ning Luo
DFI | Director of Finance/CFO | 49 | 04-09-30 |
Ji Ping Wang
BRD | Director/Board Member | 52 | 10-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Shu Ge Jiao
BRD | Director/Board Member | 58 | 15-05-31 |
Min Hua Fan
CEO | Chief Executive Officer | 63 | 92-07-13 |
Hui Fang Xie
BRD | Director/Board Member | 43 | 04-09-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 14.51 | +2.26% | 21,488,690 |
24-04-18 | 14.19 | -4.51% | 34,078,400 |
24-04-17 | 14.86 | -7.18% | 41,611,130 |
24-04-16 | 16.01 | -4.36% | 9,996,954 |
24-04-15 | 16.74 | -1.53% | 9,483,778 |
End-of-day quote Shenzhen S.E., April 18, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-35.85% | 899M | |
+24.60% | 654B | |
+24.08% | 552B | |
-5.63% | 356B | |
+15.37% | 319B | |
+7.38% | 295B | |
+3.26% | 211B | |
+0.78% | 206B | |
-9.16% | 197B | |
-9.69% | 147B |
- Stock Market
- Equities
- 300630 Stock